Microchip Technology Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$240.30M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MCHP stock price vs ORCL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Implied fair value · at MCHP's multiple
Needs MCHP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROCHIP TECHNOLOGY INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ORACLE CORP · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTEL CORP
MCHP vs INTC
TEXAS INSTRUMENTS INC
MCHP vs TXN
ADVANCED MICRO DEVICES INC
MCHP vs AMD
QUALCOMM INC/DE
MCHP vs QCOM
APPLIED MATERIALS INC /DE
MCHP vs AMAT
SKYWORKS SOLUTIONS, INC.
MCHP vs SWKS
Microsoft Corporation
MCHP vs MSFT
Amazon.com, Inc.
MCHP vs AMZN
Alphabet Inc.
MCHP vs GOOGL
International Business Machines Corporation
MCHP vs IBM
Cisco Systems, Inc.
MCHP vs CSCO
Salesforce, Inc.
MCHP vs CRM
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MCHP can sustain a major re-rating in operating margin and growth toward ORCL-like levels, then consider holding; otherwise, the data favors reducing exposure because MCHP is priced far above its implied value while posting weaker profitability and higher leverage.
MCHP’s current price of $74.29 is far above its implied P/E-based price of $4.90, indicating a -93.4% downside in this framework. The gap is especially hard to reconcile because MCHP trades at 337.7x P/E and 33.8x EV/EBITDA versus ORCL at 22.3x and 9.1x, despite ORCL delivering stronger growth and margins.
Supporting Metrics